The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Valeo Pharma has received approval for its ANDA from the FDA for Ethacrynate Sodium 50 mg.
read more
Eli Lilly announced the first patient has been enrolled in a randomized study to evaluate baricitinib, an oral JAK1/JAK2 inhibitor licensed from ...
read more
AstraZeneca Pharmaceuticals
AstraZeneca has reached an agreement with Europe’s IVA to supply up to 400 million doses of the Oxford’s COVID-19 vaccine.
read more
Arch Biopartners announced the FDA has received and acknowledged the IND Application for its lead drug Metablok to prevent acute lung and kidney organ...
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
The EIB and BioNTech SE concluded a €100 million debt financing agreement to support the development of the company’s COVID-19 vaccine program.
read more
Pfenex announced its commercialization partner, Alvogen, has launched Teriparatide Injection in the United States.
read more
Johnson & Johnson has accelerated the initiation of the Phase 1/2a first-in-human clinical trial of its investigational SARS-CoV-2 vaccine.
read more
Impel NeuroPharma announced positive results from the Company's Phase 3 study of the safety and tolerability of INP104 administered to the vascular ...
read more
Regeneron announced initiation of the first clinical trial of REGN-COV2, its investigational dual antibody cocktail for the prevention and treatment ...
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Fulcrum Therapeutics has announced plans to evaluate losmapimod as a potential treatment for patients with COVID-19.
read more
AbbVie announced new data from a study of an investigational anti-tumor necrosis factor GRM steroid antibody drug conjugate, in adult patients with ...
read more
Immunic announced receipt of regulatory allowance from the FDA to initiate its phase 2, CALVID-1 clinical trial of IMU-838.
read more
Cepheid announced the development of a next-generation test to assist global efforts in the fight against the spread of COVID-19 during the upcoming ...
read more